Charlie's (CHUC) Stock Price, News & Analysis

Company Overview

Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes non-combustible nicotine-related, alternative alkaloid vapor, and hemp-derived vapor and edible products. It sells its products through distributors, specialty retailers, and third-party online resellers in the United States, the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.

Key Stats

• Today's Range: $0.08 to $0.09
• 50-Day Range: $0.07 to $0.09
• 52-Week Range: $0.07 to $0.24
• Volume: 137,423 shs
• Average Volume: 73,052 shs
• Market Capitalization: $21.21 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHUC Stock Analysis - Frequently Asked Questions

How have CHUC shares performed this year?

Charlie's' stock was trading at $0.1198 on January 1st, 2024. Since then, CHUC shares have decreased by 29.0% and is now trading at $0.0850.
View the best growth stocks for 2024 here.

How do I buy shares of Charlie's?

Shares of CHUC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Charlie's own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Charlie's investors own include NightHawk Biosciences (NHWK), CloudCommerce (CLWD), Healthier Choices Management (HCMC), Abeona Therapeutics (ABEO), Alpine 4 (ALPP), Bantek (DRUS) and Aurora Cannabis (ACB).

Company Calendar

• Today: 11/21/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Staples
• Industry: Medicinals & botanicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CHUC
• CUSIP: N/A
• CIK: 1134765
• Web: www.charliesholdings.com
• Phone: (949) 570-0691
• Fax: 303-316-8078
• Employees: 40
• Year Founded: 2008

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-2,090,000.00
• Net Margins: -24.96%
• Pretax Margin: -20.59%
• Return on Equity: N/A
• Return on Assets: -58.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.90
• Quick Ratio: 0.30

Sales & Book Value

• Annual Sales: $16.25 million
• Price / Sales: 1.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 249,570,000
• Free Float: 193,662,000
• Market Cap: $21.21 million
• Optionable: Not Optionable
• Beta: 0.98